Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 39Neoplasms 16Neoplasm Metastasis 8Colorectal Neoplasms 5Thyroid Neoplasms 3Skin Neoplasms 2Recurrence 2Leukemia, Hairy Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid Cancer, Papillary 1Skin Diseases 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Noonan syndrome 3 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Unknown Primary 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Heterotaxy Syndrome 1Hepatoblastoma 1Glioma 1

Interventions

Irinotecan 5aflibercept 4Leucovorin 4Fluorouracil 4Cetuximab 3Bevacizumab 3regorafenib 2Oxaliplatin 2tremelimumab 1monoclonal antibody YYB-101 1masitinib 1durvalumab 1Vemurafenib 1Spectrum Analysis, Raman 1Pemetrexed 1Panitumumab 1Nivolumab 1Maraviroc 1Ipilimumab 1Indocyanine Green 1IFL protocol 1Hepatectomy 1Gemcitabine 1Drug Therapy 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colorectal Cancer Metastatic × Vemurafenib × Clear all
NCT04790448 2023-02-15

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 1/2 Completed
37 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡